Esophageal actinomycosis after allogeneic peripheral blood stem cell transplantation for extranodal natural killer/T cell lymphoma, nasal type

Bone Marrow Transplantation

Volumn 32, Issue 4, 2003, Pages 451-453

  Yagi, T ^a   Fujino, H ^a   Hirai, M ^a   Inoue, T ^a   Sako, M ^a   Teshima, H ^a   Fujii, S ^a   Hino, M ^b  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Actinomycosis; Allo PBSCT; BU CY VP 16; Nasal NK T cell lymphoma

Indexed keywords

AMPICILLIN; ANTINEOPLASTIC AGENT; BILIRUBIN; BLEOMYCIN; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; ETOPOSIDE; FLUCONAZOLE; HABEKACIN; METHOTREXATE; PIPERACILLIN; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ACTINOMYCOSIS; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTERY RUPTURE; ARTICLE; CASE REPORT; COMMON CAROTID ARTERY; ESOPHAGUS DISEASE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; T CELL LYMPHOMA;

ACTINOMYCOSIS; ADULT; BUSULFAN; CYCLOPHOSPHAMIDE; ESOPHAGEAL DISEASES; ETOPOSIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 0042889119     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704161     Document Type: Article

References (10)

1. Jaffe ES, Chan JKC, Su IJ et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Am J Surg Pathol 1996; 20: 103-111.
2. Russo TA. Agents of actinomycosis. In: Mandell GL, Bennett JE, Dolin R (eds). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, (5th edn). Churchill-Livingstone: New York, 2000, pp 2645-2654.
3. Kammoun K, Garrigue V, Bouloux C et al. Actinomycosis after renal transplantation: apropos of 1 case and review of the literature. Nephrologie 2001; 22: 21-23.
4. + NK lymphomas: clinicopathological features and prognosis. Br J Haematol 1997; 97: 821-829.
5. Okamura T, Inoue M, Yasui M et al. Identification of the Epstein-Barr virus infected cells in chronic active EB-virus infection. Igakuno-Ayumi 1998; 187: 689-690.
6. Liang R, Chen F, Lee CK et al. Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplant 1997; 19: 91-93.
7. Makita M, Maeda Y, Takenaka K et al. Successful treatment of progressive NK cell lymphoma with allogeneic peripheral stem cell transplantation followed by early cyclosporine tapering and donor leukocyte infusions. Int J Hematol 2002; 76: 94-97.
8. Imashuku S, Kuriyama K, Teramura T et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 2001; 19: 2665-2673.
9. Syed MA, Ayshford CA, Uppal HS et al. Actinomycosis of the post-cricoid space: an unusual cause of dysphagia. J Laryngol Otol 2001; 115: 428-429.
10. Lee SA, Palmer GW, Cooney EL. Esophageal actinomycosis in a patient with AIDS. Yale J Biol Med 2001; 74: 383-389.